The Prevalence of Coronary Microvascular Dysfunction in Patients With Type 2 Diabetes Mellitus
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31429 ↗At a glance
Beobachtungsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Kalyan R Chitturi and 14 co-authors. Institution: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Major MEDLINE topics: Coronary Artery Disease, Coronary Circulation, Diabetes Mellitus, Type 2, Diabetic Angiopathies. Cited 1 times so far (Crossref); 10 references. Funded by: The authors received no specific funding for this work..
Topics: Diabetes mellitus
Abstract (original language)
Patients with type 2 diabetes mellitus (DM) are more susceptible to microvascular complications. However, whether DM is associated with coronary microvascular dysfunction (CMD) is unclear. This observational study used data from the Coronary Microvascular Disease Registry (CMDR) (NCT05960474) and included patients with angina and no obstructive coronary artery disease (ANOCA) who underwent invasive CMD evaluation using the CoroVentis CoroFlow System (Abbott Vascular, Santa Clara, CA). Patient demographics, comorbidities, laboratory data, echocardiography, coronary angiography, and microvascular physiology results were analyzed. Among the 271 patients, 73 (26.9%) had DM. These patients were more likely to be African American (68.1% vs. 47.0%) and had higher rates of hypertension (93.2% vs. 74.2%), hyperlipidemia (89.0% vs. 68.7%), and chronic kidney disease (17.8% vs. 8.1%) than those without DM. Invasive coronary functional testing showed no significant differences in the index of microcirculatory resistance (IMR) (17.82 ± 8.17 vs. 19.37 ± 13.14, p = 0.268) or coronary flow reserve (CFR) (3.24 ± 1.73 vs. 3.21 ± 1.86, p = 0.909) between diabetic and nondiabetic patients. Similarly, in those testing positive for CMD, there were no significant differences in IMR (27.8 ± 7.4 vs. 32.35 ± 15.22, p = 0.108) or CFR (2.42 ± 1.09 vs. 2.05 ± 0.94, p = 0.199). Although patients with DM exhibited more comorbidities, CMD physiology indices were comparable between the groups.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
- Department of Cardiology, Creighton University School of Medicine, Phoenix, Arizona, USA.
- Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.
- Georgetown University School of Medicine, Washington, District of Columbia, USA.
- MedStar Cardiovascular Research Network, MedStar Southern Maryland Hospital Center, Clinton, Maryland, USA.
ORCID profiles: Kalyan R Chitturi, Ilan Merdler, Ron Waksman
Funding
- The authors received no specific funding for this work.
Cite
APA
Chitturi, K. R., Kumar, S., Frisancho, F. T., Rahman, S., Verma, B. R., Cellamare, M., Merdler, I., Ozturk, S. T., Cermak, V., Sawant, V., Zhang, C., Ben-Dor, I., Waksman, R., Hashim, H. D., & Case, B. C. (2025). The Prevalence of Coronary Microvascular Dysfunction in Patients With Type 2 Diabetes Mellitus. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31429
Vancouver
Chitturi KR, Kumar S, Frisancho FT, Rahman S, Verma BR, Cellamare M, et al. The Prevalence of Coronary Microvascular Dysfunction in Patients With Type 2 Diabetes Mellitus. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31429
BibTeX
@article{Chitturi2025,
author = {Chitturi, Kalyan R and Kumar, Sant and Frisancho, Flavia Tejada and Rahman, Sana and Verma, Beni Rai and Cellamare, Matteo and Merdler, Ilan and Ozturk, Sevket Tolga and Cermak, Vijoli and Sawant, Vaishnavi and Zhang, Cheng and Ben-Dor, Itsik and Waksman, Ron and Hashim, Hayder D and Case, Brian C},
title = {The Prevalence of Coronary Microvascular Dysfunction in Patients With Type 2 Diabetes Mellitus},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31429}
}
EUVIMED